1-11 of 11
Han van Krieken
Close
Sort by
Journal Articles

MYC and BCL2 mRNA Expression As Determined By NGS Predicts Survival in DLBCL in GCB but Not in ABC Subgroup

Maher Albitar, MD, Xu‐Monette Y Zijun, PhD, Yingjun Wang, Deng Manman, MD, Alexandar Tzankov, Carlo Visco, Govind Bhagat, MD, Karen Dybkær, PhD, Wayne Tam, MD PhD, Eric D. Hsi, MD, Maurilio Ponzoni, MD, Andres JM Ferreri, MD, Michael Boe Møller, Miguel A. Piris, PhD MD, Han van Krieken, MD, Ivan De Dios, BS, Youli Zu, MD PhD, Jane N Winter, MD, Hagop M. Kantarjian, MD, Yong Li, PhD, Ken H. Young
Journal: Blood
Blood (2019) 134 (Supplement_1): 5092.
https://doi.org/10.1182/blood-2019-128492
Published: 2019
Journal Articles

High frequency of inactivating tetraspanin C D37 mutations in diffuse large B-cell lymphoma at immune-privileged sites

Brief Report
Suraya Elfrink, Charlotte M. de Winde, Michiel van den Brand, Madeleine Berendsen, Margaretha G. M. Roemer, Frank Arnold, Luuk Janssen, Alie van der Schaaf, Erik Jansen, Patricia J. T. A. Groenen, Astrid Eijkelenboom, Wendy Stevens, Corine J. Hess, J. Han van Krieken, Joost S. P. Vermaat, Arjen H. G. Cleven, Ruben A. L. de Groen, Viviana Neviani, Daphne de Jong, Sjoerd van Deventer, Blanca Scheijen, Annemiek B. van Spriel
Journal: Blood
Blood (2019) 134 (12): 946–950.
https://doi.org/10.1182/blood.2019001185
Published: 2019
Includes: Supplemental data
Journal Articles

Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma

Clinical Trials & Observations
Zijun Y. Xu-Monette, Ling Li, John C. Byrd, Kausar J. Jabbar, Ganiraju C. Manyam, Charlotte Maria de Winde, Michiel van den Brand, Alexandar Tzankov, Carlo Visco, Jing Wang, Karen Dybkaer, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W. L. Choi, Jooryung Huh, Maurilio Ponzoni, Andrés J. M. Ferreri, Michael B. Møller, Ben M. Parsons, Jane N. Winter, Michael Wang, Frederick B. Hagemeister, Miguel A. Piris, J. Han van Krieken, L. Jeffrey Medeiros, Yong Li, Annemiek B. van Spriel, Ken H. Young
Journal: Blood
Blood (2016) 128 (26): 3083–3100.
https://doi.org/10.1182/blood-2016-05-715094
Published: 2016
Includes: Supplemental data
Journal Articles

MDM2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program

Zijun Y. Xu-Monette, Michael B. Møller, Alexander Tzankov, Santiago Montes-Moreno, Wenwei Hu, Ganiraju C. Manyam, Louise Kristensen, Lei Fan, Carlo Visco, Karen Dybkær, April Chiu, Wayne Tam, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W. L. Choi, J. Han van Krieken, Qin Huang, Jooryung Huh, Weiyun Ai, Maurilio Ponzoni, Andrés J. M. Ferreri, Lin Wu, Xiaoying Zhao, Carlos E. Bueso-Ramos, Sa A. Wang, Ronald S. Go, Yong Li, Jane N. Winter, Miguel A. Piris, L. Jeffrey Medeiros, Ken H. Young
Journal: Blood
Blood (2013) 122 (15): 2630–2640.
https://doi.org/10.1182/blood-2012-12-473702
Published: 2013
Includes: Supplemental data
Journal Articles

Single nucleotide variation in the TP53 3′ untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program

Yong Li, Michael W. Gordon, Zijun Y. Xu-Monette, Carlo Visco, Alexander Tzankov, Dehui Zou, Lugui Qiu, Santiago Montes-Moreno, Karen Dybkaer, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W. L. Choi, J. Han van Krieken, Qin Huang, Weiyun Ai, Maurilio Ponzoni, Andrés J. M. Ferreri, Jane N. Winter, Ronald S. Go, Miguel A. Piris, Michael B. Møller, Lin Wu, Michael Wang, Kenneth S. Ramos, L. Jeffrey Medeiros, Ken H. Young
Journal: Blood
Blood (2013) 121 (22): 4529–4540.
https://doi.org/10.1182/blood-2012-12-471722
Published: 2013
Includes: Supplemental data
Journal Articles

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

CME
Shimin Hu, Zijun Y. Xu-Monette, Alexander Tzankov, Tina Green, Lin Wu, Aarthi Balasubramanyam, Wei-min Liu, Carlo Visco, Yong Li, Roberto N. Miranda, Santiago Montes-Moreno, Karen Dybkaer, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W. L. Choi, Xiaoying Zhao, J. Han van Krieken, Qin Huang, Jooryung Huh, Weiyun Ai, Maurilio Ponzoni, Andrés J. M. Ferreri, Fan Zhou, Graham W. Slack, Randy D. Gascoyne, Meifeng Tu, Daina Variakojis, Weina Chen, Ronald S. Go, Miguel A. Piris, Michael B. Møller, L. Jeffrey Medeiros, Ken H. Young
Journal: Blood
Blood (2013) 121 (20): 4021–4031.
https://doi.org/10.1182/blood-2012-10-460063
Published: 2013
Includes: Supplemental data
Journal Articles

CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

Shimin Hu, Zijun Y. Xu-Monette, Aarthi Balasubramanyam, Ganiraju C. Manyam, Carlo Visco, Alexander Tzankov, Wei-min Liu, Roberto N. Miranda, Li Zhang, Santiago Montes-Moreno, Karen Dybkær, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, William W. L. Choi, J. Han van Krieken, Qin Huang, Jooryung Huh, Weiyun Ai, Maurilio Ponzoni, Andrés J. M. Ferreri, Xiaoying Zhao, Jane N. Winter, Mingzhi Zhang, Ling Li, Michael B. Møller, Miguel A. Piris, Yong Li, Ronald S. Go, Lin Wu, L. Jeffrey Medeiros, Ken H. Young
Journal: Blood
Blood (2013) 121 (14): 2715–2724.
https://doi.org/10.1182/blood-2012-10-461848
Published: 2013
Includes: Supplemental data
Journal Articles

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

Clinical Trials & Observations
Zijun Y. Xu-Monette, Lin Wu, Carlo Visco, Yu Chuan Tai, Alexander Tzankov, Wei-min Liu, Santiago Montes-Moreno, Karen Dybkær, April Chiu, Attilio Orazi, Youli Zu, Govind Bhagat, Kristy L. Richards, Eric D. Hsi, X. Frank Zhao, William W. L. Choi, Xiaoying Zhao, J. Han van Krieken, Qin Huang, Jooryung Huh, Weiyun Ai, Maurilio Ponzoni, Andrés J. M. Ferreri, Fan Zhou, Brad S. Kahl, Jane N. Winter, Wei Xu, Jianyong Li, Ronald S. Go, Yong Li, Miguel A. Piris, Michael B. Møller, Roberto N. Miranda, Lynne V. Abruzzo, L. Jeffrey Medeiros, Ken H. Young
Journal: Blood
Blood (2012) 120 (19): 3986–3996.
https://doi.org/10.1182/blood-2012-05-433334
Published: 2012
Includes: Supplemental data
Journal Articles

Use of RNA Electroporated DC for Activation of LRH-1 Specific Cytotoxic T Lymphocytes in the Treatment of Lymphoid Malignancies.

Ingrid Overes, Hanny Fredrix, Bjorn de Rijke, Agnes van Horssen-Zoetbrood, Han van Krieken, Reinier Raymakers, Robbert van der Voort, T.M. de Witte, Harry Dolstra
Journal: Blood
Blood (2006) 108 (11): 138.
https://doi.org/10.1182/blood.V108.11.138.138
Published: 2006
Journal Articles

Profiling of Caspase Signaling Pathways Predicts Clinical Response to Chemotherapy in Diffuse Large B-Cell Lymphomas.

Joost J. Oudejans, MD, PhD, Jettie J.F. Muris, MD, Gert J. Ossenkoppele, MD, PhD, Saskia A.G.M. Cillessen, Inge van Houdt, Alain J. Kummer, MD, PhD, Han van Krieken, MD, PhD, Hanneke C. Kluin-Nelemans, MD, PhD, Chris J.L.M. Meijer, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 1544.
https://doi.org/10.1182/blood.V104.11.1544.1544
Published: 2004
Journal Articles

ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma

Brief Report
Pascale De Paepe, Mathijs Baens, Han van Krieken, Bruno Verhasselt, Michel Stul, Annet Simons, Bruce Poppe, Geneviève Laureys, Paul Brons, Peter Vandenberghe, Frank Speleman, Marleen Praet, Chris De Wolf-Peeters, Peter Marynen, Iwona Wlodarska
Journal: Blood
Blood (2003) 102 (7): 2638–2641.
https://doi.org/10.1182/blood-2003-04-1050
Published: 2003